News Research Genetics/Genomics Lung Cancer

Comparing Accuracy of Open-Source AI Models for EGFR Mutation Prediction in Lung Adenocarcinoma

Open-source AI pathology models can help to predict the presence of EGFR mutations in samples from patients with lung adenocarcinoma. However, differences are found between models, especially when accounting for ancestral subgroups.

March 03, 2026 By Matthew Stenger 3 min read

ASCO AI in Oncology is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO^®). The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.

KOL Commentary

Watch

Comparing Accuracy of Open-Source AI Models for EGFR Mutation Prediction in Lung Adenocarcinoma

0 Key Takeaways

Related Content